JFGIW
TAK icon

Johnson Financial Group Inc (Wisconsin)’s Takeda Pharmaceutical TAK Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57
Closed -$814 – 979
2023
Q4 		$814 Buy
+57
New +$809 ﹤0.01% 801

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s TAK Position: Q1 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 57 shares — an estimated $814 sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in TAK in Q4 2023 and held it in 1 quarter. The position peaked at $814 in Q4 2023. 315 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 57 Takeda Pharmaceutical shares in Q1 2024, an estimated $814.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Takeda Pharmaceutical in Q4 2023 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Takeda Pharmaceutical position peaked at $814 in Q4 2023.
  • 315 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2024, filed 14 May 2024.